Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 300

    Mylan launches generic Mutamycin injection in US

    Mylan launches generic Mutamycin injection in US

    Ruby Khatun Khatun23 March 2018 10:30 AM IST
    Global pharmaceutical company Mylan NV announced the U.S. launch of the oncology drug Mitomycin for Injection USP, 5 mg/vial, 20 mg/vial and 40...
    Novartis touts US filing plans for MS drug as patent losses loom

    Novartis touts US filing plans for MS drug as patent losses loom

    Ruby Khatun Khatun23 March 2018 10:15 AM IST
    ZURICH: Novartis plans to file its BAF312 multiple sclerosis drug for U.S. approval within weeks, the Swiss drugmaker said, as it seeks to refresh its...
    Reckitt Benckiser pulls out of Pfizer consumer health auction

    Reckitt Benckiser pulls out of Pfizer consumer health auction

    Ruby Khatun Khatun23 March 2018 10:00 AM IST
    British consumer goods maker Reckitt Benckiser Group said it had ended discussions with Pfizer Inc over buying its consumer healthcare business, a day...
    Bayer gets European Commission nod for Monsanto deal

    Bayer gets European Commission nod for Monsanto deal

    Ruby Khatun Khatun23 March 2018 9:45 AM IST
    New Delhi: German chemical and pharma major Bayer said it has received "conditional" approval from the European Commission for its proposed USD 66...
    FDA seeks data on role of flavors in tobacco addiction

    FDA seeks data on role of flavors in tobacco addiction

    Ruby Khatun Khatun23 March 2018 9:30 AM IST
    The U.S. Food and Drug Administration asked for data, research and public comment on the role that flavors such as menthol play in tobacco addiction,...
    Sun Pharma gets USFDA approval for plaque psoriasis drug

    Sun Pharma gets USFDA approval for plaque psoriasis drug

    Ruby Khatun Khatun22 March 2018 11:00 AM IST
    Mumbai: Sun Pharmaceutical Industries announced that it has received approval from the US Food and Drug Administration (FDA) for Ilumya...
    NATHEALTH elects Daljit Singh as president

    NATHEALTH elects Daljit Singh as president

    Ruby Khatun Khatun22 March 2018 10:30 AM IST
    New Delhi: Healthcare Federation of India NATHEALTH said Fortis Healthcare president Daljit Singh has been elected as its president for the year...
    GlaxoSmithKline prescribes commercial reboot for pharma division

    GlaxoSmithKline prescribes commercial reboot for pharma division

    Ruby Khatun Khatun22 March 2018 10:00 AM IST
    LONDON: In January, GlaxoSmithKline's new head of pharmaceuticals Luke Miels issued a blunt challenge to his managers: find budget savings of 20...
    Arena Pharmas bowel disease drug meets study goal

    Arena Pharma's bowel disease drug meets study goal

    Ruby Khatun Khatun22 March 2018 9:45 AM IST
    Arena Pharmaceuticals Inc said a higher dose of its experimental drug succeeded in improving symptoms associated with ulcerative colitis, a chronic...
    UK-US firms create largest genomics project to study Indian population

    UK-US firms create largest genomics project to study Indian population

    Ruby Khatun Khatun22 March 2018 9:30 AM IST
    London: A UK-based genomics data platform and an American genetics company collaborated to create the world's largest project of its kind to study...
    Cipla gets USFDA observations for its Goa plant

    Cipla gets USFDA observations for its Goa plant

    Ruby Khatun Khatun21 March 2018 11:00 AM IST
    New Delhi: Drug firm Cipla said it has received observations from the US health regulator for its Goa plant which are procedural in nature.The United...
    65 percent of misleading Ayush ads withdrawn following complaints: Parliamentary panel

    65 percent of misleading Ayush ads withdrawn following complaints: Parliamentary panel

    Ruby Khatun Khatun21 March 2018 10:30 AM IST
    New Delhi: Appreciating the efforts made by the AYUSH Ministry to monitor misleading advertisements on herbal products, a Parliamentary panel has...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok